RSV season typically runs from October to April, peaking in December or January, affecting high-risk groups such as young children and seniors. Prevention recommendations include administering Beyfortus to infants and Abrysvo to pregnant women. Vaccination for seniors should ideally occur in late summer or early fall for optimal protection against RSV.
Seasonal Recommendations to Prevent RSV Read More »
Larry Palevsky opposes Beyfortus for RSV, claiming there’s no history of monoclonal antibodies for children. However, numerous examples, like Synagis for RSV since 1998, contradict this. Additionally, RSV is a serious illness. Skepticism towards anti-vaccine misinformation is crucial for informed decisions about necessary medical treatments for children.
The Truth About RSV and Monoclonal Antibodies Read More »
The claim that Big Pharma profits greatly from the hepatitis B vaccine overlooks the reality that treating chronic hepatitis B is far more expensive. While the vaccine costs about $17 per dose, treatments for chronic infections can reach tens of thousands. Vaccination is thus a cost-effective way to prevent severe health outcomes.
Vaccination is essential for patients with paroxysmal nocturnal hemoglobinuria (PNH) prior to receiving treatments like eculizumab and iptacocan, as these medications increase the risk of vaccine-preventable diseases. Specifically, meningococcal vaccines are mandated due to the heightened risk of meningococcal disease in individuals receiving complement inhibitor therapy.
Show Me The Insert – PNH Medications Edition Read More »
You must be logged in to post a comment.